Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Selvi Pradeepan"'
Autor:
Harish Shankaran, Abhishek G. Sathe, Jennifer C. Sasaki, Aixiang Xue, Per E. Andrén, Selvi Pradeepan, Anna Nilsson, Richard J. A. Goodwin, Natalie Keirstead, Anshul Gupta, Richard T. Gallagher, John G. Swales
Publikováno v:
Chemical Research in Toxicology. 28:1823-1830
Colistin and polymyxin B are effective treatment options for Gram-negative resistant bacteria but are used as last-line therapy due to their dose-limiting nephrotoxicity. A critical factor in developing safer polymyxin analogues is understanding accu
Autor:
Selvi Pradeepan, Chet Metcalf, Brendan F. Boyce, Shuangying Liu, Manfred Weigele, Surinder S. Narula, Regine S. Bohacek, Lianping Xing, Raji Sundaramoorthi, Jeff Keats, Julie Bogus, Jennifer Saltmarsh, Yihan Wang, Scott Wardwell, Mary K. Ram, David C. Dalgarno, John Iuliucci, Susan Adams, Guru Paramanathan, Shuenn Liou, Marie Rose van Schravendijk, Anne Dilauro, Sonya Roeloffzen, T. Keenan, William C. Shakespeare, Tomi K. Sawyer
Publikováno v:
Chemical Biology & Drug Design. 71:97-105
Targeted disruption of the pp60(src) (Src) gene has implicated this tyrosine kinase in osteoclast-mediated bone resorption and as a therapeutic target for the treatment of osteoporosis and other bone-related diseases. Here, we describe structure acti
Autor:
Selvi Pradeepan, Taylor Merry, Shelia Violette, Surinder S. Narula, Noriyuki Kawahata, Yihan Wang, Tomi K. Sawyer, David C. Dalgarno, Susan Adams, George P. Luke, Terence P. Keenan, Regine S. Bohacek, Wei Guan, Marie Rose van Schravendijk, Raji Sundaramoorthi, Jeffrey A. Keats, Mary K. Ram, Evelyn G. Corpuz, Chi B. Vu, Manfred Weigele, Chester A. Metcalf, Shuenn Liou, William C. Shakespeare
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 13:3071-3074
The design of bone-targeted pyrido[2,3-d]pyrimidin-7-ones as Src tyrosine kinase inhibitors is described. Leveraging SAR from known compounds and using structure-based methods, we were able to rapidly incorporate bone binding components, which mainta
Autor:
Taylor Merry, Selvi Pradeepan, Raji Sundaramoorthi, Virginia A. Jacobsen, Mayumi Uesugi, Vaibhav Varkhedkar, Chi B. Vu, Chester A. Metcalf, Jeremy Green, Dennis A. Holt, Edgardo Laborde, Karina J. Macek, Yinka Green
Publikováno v:
Tetrahedron Letters. 39:3435-3438
An efficient method for the preparation of protected phosphate ester-linked resins in high yield and purity is presented. Variation in tether length/functionality and substitution pattern of the phenol precursors, as well as mild deprotection conditi
Autor:
Peter Doig, Sameer Kawatkar, P. Ann Boriack-Sjodin, James T. Loch, Linda G. Otterson, Amy Kutschke, Selvi Pradeepan, Gabriel Martínez-Botella, Nelson B. Olivier, Joseph V. Newman, Satenig Guler, Oluyinka Green, Jacques Dumas, Andrew R. McKenzie, Eric Gangl, John Breen, Swati Prasad, Beth Andrews, Martin F. Hentemann, Diane Joseph-McCarthy, Thomas A. Keating
Publikováno v:
ACS chemical biology. 7(11)
There is an urgent need for new antibacterials that pinpoint novel targets and thereby avoid existing resistance mechanisms. We have created novel synthetic antibacterials through structure-based drug design that specifically target bacterial thymidy
Autor:
Chester A. Metcalf, Ukti Mani, Shiela M. Violette, Tomi K. Sawyer, Susan Adams, Yihan Wang, Terence P. Keenan, Regine S. Bohacek, Marie Rose van Schravendijk, Mary K. Ram, David C. Dalgarno, Selvi Pradeepan, Raji Sundaramoorthi, William C. Shakespeare, Jeffrey A. Keats, Surinder S. Narula, Chad Haraldson, Manfred Weigele, Shuenn Liou
Publikováno v:
Bioorganicmedicinal chemistry letters. 13(18)
Novel bone-targeted 2,6,9-trisubstituted purine template-based inhibitors of Src tyrosine kinase are described. Drug design studies of known purine compounds revealed that both positions-2 and -6 were suitable for incorporating bone-seeking moieties.
Autor:
Chad Haraldson, Taylor Merry, Tomi K. Sawyer, Karin Stebbins, Marcos Hatada, Franklin Cerasoli, Surinder S. Narula, David C. Dalgarno, William C. Shakespeare, Marie Rose van Schravendijk, Jay Herson, Selvi Pradeepan, John Iuliucci, Manfred Weigele, Raji Sundaramoorthi, Xiaode Lu, Jeremy Smith, Mihai Azimioara, Susan Adams, Chester A. Metcalf, Shelia Violette, Chi B. Vu, Regine S. Bohacek, Michael Yang, Wei Guan, Catherine Bartlett
Targeted disruption of the pp60 src (Src) gene has implicated this tyrosine kinase in osteoclast-mediated bone resorption and as a therapeutic target for the treatment of osteoporosis and other bone-related diseases. Herein we describe the discovery
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4c5b835f12945cdcdbb7f6a31d14980
https://europepmc.org/articles/PMC16871/
https://europepmc.org/articles/PMC16871/
Autor:
Selvi Pradeepan, Chi B. Vu, Tomi K. Sawyer, Shelia Violette, van Schravendijk Mr, Ian A. MacNeil, Catherine Bartlett, Mary K. Ram, Botfield Mc, Charles J. Eyermann, Berkley A. Lynch, Taylor Merry, Evelyn G. Corpuz, Regine S. Bohacek
Publikováno v:
Journal of medicinal chemistry. 42(20)
A series of 1,2,4-oxadiazole analogues has been shown to be potent and selective SH2 inhibitors of the tyrosine kinase ZAP-70, a potential therapeutic target for immune suppression. These compounds typically are 200-400-fold more potent than the nati